Amandine Luquiens

✨ Very happy and honored ✨ to have been interviewed for this podcast 🎙️ accompanying our article recently published in Addiction 📄.
These findings will now be extended through a phase 3 study, funded by the PHRC-N program of the French Ministry of Health 🇫🇷📊. #Psilocybin #addiction #alcohol

Aerial shot of the groceries section in a supermarket. Copyright: Peter Bond on Unsplash.

The rise of ultra-processed foods is damaging public health, fuelling chronic diseases worldwide, and deepening health inequalities.

Urgent, coordinated global action is needed to address the UPF challenge.

Find out more in an Editorial ➡️ spkl.io/63327AgUC1

Exclusive: ex-CDC director talks about why she was fired “I would never do that, as a scientist,” Susan Monarez says of being asked to approve changes to vaccine recommendations without knowing the details.

Exclusive: "The CDC is far too important to just give up on" says Susan Monarez, who was director of the CDC for just 29 days under the current administration

go.nature.com/4pSmanQ

@esbrasociety.bsky.social @benjaminrolland.bsky.social @pierremaurage.bsky.social @deminamimi.bsky.social

✨ Excited to present at ESBRA in Brussels our preliminary results:
👉 Patients’ early emergence of adaptive coping strategies predicts psilocybin treatment response at 3 months.
👉 First CNS BMQ signals related to neuroplasticity add to the picture.
Rich exchanges & inspiring encounters last week! 🌍💡

Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial - PubMed Psilocybin-assisted psychotherapy appears feasible, acceptable, and safe in recently detoxified patients with comorbid alcohol use disorder and depression.

@psychedelique-fr.bsky.social @addictaide.bsky.social @addictionsfrance.bsky.social @zoe-dubus.bsky.social @existwell.bsky.social @drfriid.bsky.social @robincarhartharris.bsky.social @katrinpreller.bsky.social @luscher.bsky.social pubmed.ncbi.nlm.nih.gov/40702912/

Et si les champignons hallucinogènes devenaient un traitement efficace contre l’alcoolisme et la dépression ? La recherche s’intéresse aux pouvoirs de la psilocybine – et autres psychédéliques interdits en usage clinique – sur les addictions et les dépressions.

📰 Another one! Le Point adds to the wide media coverage of our Psilocybin–Alcohol–Depression study. l.lepoint.fr/DYL
France’s 1st psychedelic renaissance trial shows:
✨ society’s demand for new options as psychiatry & addiction care hit limits
✨ the need for rigorous science to test them.

👉 Putting an end to the guilt and stigma faced by people living with addiction, and moving away from terms like “responsible gambling.”
👉 Shedding light on the therapeutic hope carried by #psychedelics
@addictaide.bsky.social @addictionsfrance.bsky.social @chudenimes.bsky.social

« En addictologie, il y a un principe simple : pour faire avancer quelqu’un, on passe par la gratification, pas la punition » Alors que le ministre de l’Intérieur assume d’avoir lancé une « campagne de culpabilisation » des usagers de cocaïne, les psychiatres Amine Benyamina et Amandine Luquiens questionnent nos politiques p...

In @nouvelobs.com, together with Amine Benyamina, we highlight key messages to guide public policies on #addiction.
www.nouvelobs.com/societe/2025...

Exclusive: retraction-prone editors identified at megajournal PLoS ONE Study says small editor group handled many problematic manuscripts — and a Nature investigation finds out who they are.

Nearly one-third of all retracted papers at PLoS ONE can be traced back to just 45 researchers who served as editors at the journal

go.nature.com/3UITVts

Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial buff.ly/p13RswF
@luquiensa.bsky.social

The study was in people with alcohol use disorder recently detoxified and with persitent depressive symptoms Very promising results!

Endless thanks to our patients for their trust and to the whole team ❤️ #psychedelics #addictionresearch

Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial Background and Aims Psilocybin has emerged as a potential treatment for alcohol use disorder (AUD), but early efficacy data are inconsistent. Depression following alcohol detoxification significantl...

Thrilled to share our newly published article in @AddictionJrnl : the first French study using psychedelics in a medical setting since research resumed.

At 3 months, abstinence rates were 5 times higher in the group receiving two 25 mg doses of psilocybin.
onlinelibrary.wiley.com/doi/10.1111/...

Session on Gambling Disorder Treatment at the ICBA in Nantes this week. Psychotherapy, family approaches, contingency management, limitations of player account data—very insightful discussions! Many thanks to the organizers and speakers. @issba.bsky.social

Thanks to the organizers of the 5th International Multidisciplinary Symposium on excessive gambling for giving me the opportunity to present the results of the study DEBUTER, highlighting the role of gambling addiction in suicidal ideation among medical students

Thank you for this wonderful opportunity to present the results of the PAD study and to hear such inspiring talks!

du-diu-facmedecine.umontpellier.fr/diplome-addi...

du-diu-facmedecine.umontpellier.fr/diplome-addi...

En visio sur 2 modules et 3e module présentiel aux beaux jours à Montpellier @emelinechauchard.bsky.social @joelbillieux.bsky.social @marieroustide.bsky.social @gsescousse.bsky.social @gabthor.bsky.social @oulmann.bsky.social @loisfournier.bsky.social

J'ai le plaisir de vous inviter à vous inscrire au nouveau et seul diplôme interuniversitaire français "addictions comportementales"! Une formation théorique et clinique approfondie qui développe une approche critique et pluriprofessionnelle avec les plus grands experts francophones du champ!

The entire National Survey on Drug Use and Health (NSDUH) team at SAMHSA was terminated today.

Do not listen to the platitudes of this administration when they say they care about drug overdose, addiction, mental health, or suicide.

Federal Agency Dedicated to Mental Illness and Addiction Faces Huge Cuts The Substance Abuse and Mental Health Services Administration has already closed offices and could see staff numbers reduced by 50 percent.

The Substance Abuse and Mental Health Services Administration works on two of the most urgent U.S. health problems and has generally received bipartisan support. By the end of this week, the staff of the agency could be cut by 50%, according to senior staff members.

#psychedelic #addiction

Very happy to speak at this conference to present the results of the PAD study!
thank you for inviting me @lucieberko.bsky.social @Afpbn

@inserm.fr @umontpellier.bsky.social @doyensdemedecine.bsky.social @marieroustide.bsky.social

A reminder that academics have always been the first to be systematically targeted by autocrats upon taking power because knowledge and understanding serve as the true counterpower. Let us remember this and bend the course of history to avoid repeating the mistakes of the past.

#StandUpForScience Montpellier, France: Several hundred people—researchers, teachers, children, supporters, and institutional representatives, including the president of the University of Montpellier—gathered to support American scientists and stand up against censorship.

All our support from Montpellier France !

Rdv sur standupforscience.fr pour trouver le plus proche de chez vous et à Montpellier à 18h place de la comédie ! Pour en savoir plus lisez la tribune publiée aujourd'hui www.lemonde.fr/sciences/art...

En écho au mouvement américain de protestation contre la politique obscurantiste de censure des scientifiques menée par Donald Trump et en miroir de la marche #Standupforscience prévue aux US le 7 mars, des rassemblements de soutien ont lieu partout en France.